What medications are used for induction of anesthesia for Electroconvulsive Therapy (ECT)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Medications Used for Induction of Anesthesia for ECT

Methohexital at 1.0 mg/kg IV is the preferred anesthetic agent for ECT induction, with acceptable alternatives including etomidate, thiopental sodium, ketamine, and propofol. 1, 2

Primary Anesthetic Agents

First-Line Agent

  • Methohexital is the most commonly used and recommended anesthetic agent at a standard dose of 0.75-1.0 mg/kg IV 1, 2, 3
  • This barbiturate provides rapid induction with appropriate seizure characteristics and recovery profiles 3

Alternative Anesthetic Agents

When methohexital is contraindicated or unavailable, the following alternatives are acceptable:

  • Etomidate: Produces longer seizure durations than methohexital (24% longer mean wakeup time), with comparable hemodynamics but higher incidence of injection pain 2, 4
  • Thiopental sodium: Acceptable barbiturate alternative 1
  • Ketamine: Produces the longest seizures and may have proconvulsant properties 2, 5
  • Propofol: Results in the shortest seizure durations and may require higher stimulus dosing, more bilateral treatments, and more total ECT sessions, particularly with unilateral electrode placement 5, 6

Important caveat: Propofol should be used cautiously as it is associated with significantly shorter seizures, higher restimulation rates for brief seizures, and increased need for bilateral ECT compared to methohexital 6

Muscle Relaxants

  • Succinylcholine at 0.5-1.0 mg/kg IV is the standard muscle relaxant 1, 2, 3
  • Atracurium and mivacurium are acceptable alternatives 1, 2

Anticholinergic Medications

  • Atropine (IV) or glycopyrrolate should be administered immediately before ECT to prevent bradycardia, arrhythmia, or cardiac asystole 1, 2
  • These agents are required before seizure threshold determination by dose titration and before the first treatment with right unilateral electrode placement to protect against vagal discharge 1, 2

Adjunctive Agents for Hemodynamic Control

For patients at risk from tachycardia and hypertension during ECT:

  • Nitroglycerin, propranolol, hydralazine, or other sympatholytic agents should be used to attenuate cardiovascular responses 3
  • Remifentanil (500 mcg IV bolus) combined with low-dose methohexital (40 mg IV) significantly reduces heart rate and blood pressure responses throughout the procedure 7

Ventilation Protocol

  • 100% oxygen must be administered via ventilation before electrical stimulus delivery 1, 2
  • Manual hyperventilation with 100% oxygen may improve seizure quality by optimizing the pO2/pCO2 ratio 5

Special Considerations for Combination Therapy

  • Ketamine + propofol (1:1 ratio) may yield seizures with the best quality characteristics 5
  • This combination balances propofol's anticonvulsant properties with ketamine's proconvulsant effects 5

Agents for Terminating Prolonged Seizures

If seizures exceed 180 seconds (occurring in 0-10% of treatments):

  • Additional methohexital, diazepam, or lorazepam can effectively terminate prolonged seizures 2, 8

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Anesthetic Regimens for ECT Sessions

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Anesthetic considerations for electroconvulsive therapy.

Southern medical journal, 1992

Guideline

Medications to Discontinue Prior to Electroconvulsive Therapy (ECT)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.